| Financial Year |
March 31 2023 |
| Monetary Funds |
9,083,474,726.39 |
| Held-for-trading Financial Assets |
3,621,000,000.00 |
| Notes Receivable |
1,490,503,723.56 |
| Accounts Receivable |
3,400,340,764.09 |
| Advances to Suppliers |
1,418,174,114.02 |
| Other Receivables |
44,630,290.98 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,591,628,748.94 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
98,821,475.94 |
| Total Current Assets |
21,744,725,837.15 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
3,226,929.78 |
| Investment Properties |
82,806,788.23 |
| Fixed Assetes |
157,261,915.83 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
7,007,975,961.50 |
| R&D expenses |
123,795,003.70 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
80,951,329.05 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
8,711,392.81 |
| Sub-Total of Non-Current Assets |
7,738,210,734.76 |
| Total Assets |
29,482,936,571.91 |
| Short-Term Loans |
1,378,522,251.04 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,705,827,979.23 |
| Accounts Payable |
4,859,194,181.53 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
553,010,339.52 |
| Taxes Payable |
181,322,301.27 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
105,143,090.55 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
81,475,404.91 |
| Other Current Liabilities |
104,492,505.26 |
| Sub-Total of Current Liabilities |
9,931,826,750.27 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
7,496,213.00 |
| Deferred Income Tax Liabilities |
16,503,825.84 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
232,670,849.56 |
| Total Liabilities |
10,164,497,599.83 |
| Paid-In Capital(Or Share Stock) |
1,870,720,815.00 |
| Capital Surplus |
9,546,797,532.04 |
| Surplus Reserve |
126,108,937.21 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
7,836,690,947.51 |
| Minority Stockholder's Interest |
-61,981,453.67 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
19,380,420,425.75 |
| Owner's Equity（Stockholder's Equity） |
19,318,438,972.08 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
29,482,936,571.91 |
